ABOUT THE EVENT
Date: Monday, August 31, 2026 8am–5:30pm PDT
Event Location: San Francisco, California
Consider a day spent alongside the senior experts shaping the future of biologics production, engineers, scientists, and decision-makers from across pharma and biotech, all focused on advancing antibody manufacturing. That is what the Antibody Manufacturing Xchange San Francisco 2026 offers. This invitation-only, highly curated meeting provides access to senior expertise and the opportunity to build meaningful relationships that can influence manufacturing strategy and pipeline success.
Across five dedicated tracks, Cell Line Development, Upstream Development, Downstream Processing and Purification, Formulation and Stability, and Quality Control and Characterization, attendees will explore the practical challenges of scaling antibody production. Discussions span key areas such as multispecific expression, process optimisation, impurity removal, stability forecasting, and analytical robustness, with each session grounded in real-world experience and current industry demands.
The agenda is designed to maximise interaction and value, combining keynote sessions, spotlight and poster presentations, roundtables, and pre-scheduled one-to-one meetings with industry specialists. Structured networking throughout the day, including breaks, lunch, and a closing drinks reception, ensures ample opportunity to connect with peers, exchange insights, and identify potential collaborations.
Taking place in San Francisco on Tuesday 1st September 2026 at the DoubleTree by Hilton San Francisco Airport Hotel, this Xchange provides access to a focused community of experts working at the forefront of antibody manufacturing. Registration is complimentary for qualified attendees.
